Molecular tests found a pathogenic variant in GCK gene, confirming GCK-MODY diabetes and additionally a heterozygous pathogenic variant in the GJB2 gene that identified the patient as a carrier of nonsyndromic hearing loss, and a heterozygous variant in the WFS1 gene (c.68C>T). This evidence concerns the gene GCK and hearing loss disorder.